ArticleInvestigational new drugs2018

AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair.

Lilach Moyal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.